Patents by Inventor Hédi Mohamed Haddada

Hédi Mohamed Haddada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Defective recombinant adenoviruses expressing cytokines for antitumor treatment
    Patent number: 7306793
    Abstract: A recombinant nucleic acid used for the production of a defective adenovirus containing an inserted sequence coding for a cytokine under the control of a promoter in the genomic sequence of the recombinant adenovirus. This recombinant adenovirus is useful in the preparation of anti-tumoral drugs which can be directly injected into the tumor of the host.
    Type: Grant
    Filed: September 13, 2004
    Date of Patent: December 11, 2007
    Assignees: Centre National de la Recherche Scientifique, Institut Gustave Roussy
    Inventors: Hédi Mohamed Haddada, Thierry Ragot, Michel Perricaudet
  • Defective recombinant adenoviruses expressing cytokines for antitumor treatment
    Patent number: 6811774
    Abstract: A recombinant nucleic acid used for the production of a defective adenovirus containing an inserted sequence coding for a cytokine under the control of a promoter in the genomic sequence of the recombinant adenovirus. This recombinant adenovirus is useful in the preparation of anti-tumoral drugs which can be directly injected into the tumor of the host.
    Type: Grant
    Filed: December 3, 1998
    Date of Patent: November 2, 2004
    Assignees: Centre National de la Recherche Scientifique, Institut Gustave Roussy
    Inventors: Hedi Mohamed Haddada, Thierry Ragot, Michel Perricaudet